Print

CytRx Corporation (CYTR) Reports Second Quarter 2012 Financial Results  
8/9/2012 10:25:30 AM

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today reported financial results for the three months and six months ended June 30, 2012, and provided a business update.
//-->